Related by context. All words. (Click for frequent words.) 66 LHRH receptor positive 66 metastatic pancreatic 65 metastatic gastric 65 resistant hormone refractory 65 recurrent glioblastoma multiforme 64 Squamous 64 recurrent metastatic 64 metastatic malignant 64 cisplatin gemcitabine 64 Temodar ® 64 LUNG CANCER 63 5 fluorouracil leucovorin 63 LungAlert TM 63 hormone refractory metastatic prostate 63 metastatic renal 63 acute myeloid 63 essential thrombocythemia ET 63 GOUT 63 NMIBC 63 Temsirolimus 63 malignant ascites 63 abacavir Ziagen 63 Pegylated Interferon 62 refractory chronic lymphocytic 62 CANCERS 62 papillary renal cell carcinoma 62 Heterozygous Familial Hypercholesterolemia 62 breast endometrial 62 commercialize deforolimus 62 PROSTATE 62 Patients Receiving 62 Monoclonal antibody 62 unresectable tumors 62 relapsed MM 62 Allogeneic 62 chronic myeloid 62 TO AVOID PREGNANCY WHILE 62 CARDIOVASCULAR 62 Safinamide 62 breast pancreatic 62 deep venous thromboses 62 pediatric acute lymphoblastic 62 invasive lobular 62 TNFerade TM 62 thalidomide Thalomid 62 bladder ovarian 61 Immunotherapeutic 61 Complicated Skin 61 Arimidex anastrozole 61 T1c 61 Basal Cell 61 CYT# potent vascular disrupting 61 Sezary syndrome 61 Improves Outcomes 61 Quinamed 61 Bayer Nexavar 61 metastatic GIST 61 ® lenalidomide 61 Soft Tissue Sarcoma 61 See WARNINGS 61 HEPATITIS C 61 advanced hepatocellular carcinoma 61 thromboembolic disease 61 Chronic lymphocytic leukemia 61 Patients Treated With 61 Leukemias 61 undergoing radical cystectomy 61 hepatocellular carcinoma liver 61 chronic thromboembolic pulmonary 61 BREAST CANCER 61 Advanced Melanoma 61 Papillary 61 Non Alcoholic Steatohepatitis 61 metastatic bladder 61 Hodgkin lymphoma HL 61 demonstrated antitumor activity 61 Adjuvant Chemotherapy 61 Candida infection 61 Adjuvant chemotherapy 61 autosomal dominant polycystic kidney 61 HER2 amplified 61 FDA APPROVES 61 Hormone Refractory Prostate Cancer 61 smoldering myeloma 61 Mitomycin C 61 LymphoStat B belimumab 61 Acute Renal Failure 61 SUFFERERS 61 Combination REOLYSIN R 61 ovary uterus 61 IN PATIENTS WITH 60 evaluating tivozanib 60 Prospective Randomized 60 CIMZIA TM certolizumab pegol 60 leukemia lymphomas 60 treat benign prostatic 60 bladder prostate 60 GW# [003] 60 Xelox 60 Aflibercept 60 biliary tract cancer 60 Thromboembolism 60 CERVICAL 60 cell carcinoma RCC 60 Amgen Neulasta R 60 Antitumor Activity 60 Cimzia TM 60 biliary cancer 60 Vulvar 60 kidney urologic 60 skeletal metastases 60 Anthracycline 60 Metastatic breast cancer 60 basal cell skin 60 metastatic colorectal 60 cetuximab Erbitux 60 Vidaza azacitidine 60 Diabetic Neuropathy 60 mycosis fungoides 60 Parathyroid Hormone 60 Heart Failure Patients 60 Surgical resection 60 Chemoradiation 60 Microalbuminuria 60 See CLINICAL PHARMACOLOGY 60 Sanofi Aventis Taxotere 60 Waldenstrom macroglobulinemia 60 radioimmunotherapy RIT 60 primary hyperparathyroidism 60 Ferinject R 60 vinca alkaloid 60 Relapsed Refractory 60 ovarian cervical 60 Sprycel dasatinib 60 DIAGNOSED 60 Subtypes 60 Nat Rev 60 lexidronam injection 60 Phase #b/#a clinical 60 Intravitreal 60 Bevacizumab Avastin 60 CTAP# 60 bile duct cancers 60 Neoadjuvant 60 Tesmilifene 60 corticosteroid dexamethasone 60 advanced medullary thyroid 60 STENT 60 Node Positive 60 mutated K ras 60 ErbB2 positive 59 Adjuvant Treatment 59 brain metastases originating 59 Sjogren Syndrome 59 AVONEX ® 59 NSABP B 59 Aplidin 59 peritoneal cancer 59 Trandolapril 59 Gemzar gemcitabine 59 histological subtype 59 Philadelphia Chromosome Positive 59 Thal Dex 59 AVASTIN 59 gefitinib Iressa 59 FUSILEV enhances 59 Endometrial cancer 59 HBeAg negative 59 Squamous Cell 59 CLINICAL PHARMACOLOGY 59 nonmetastatic 59 HER2 Positive Breast Cancer 59 pegylated liposomal doxorubicin 59 Selective Internal 59 breast uterine 59 Epirubicin 59 liposomal amphotericin B 59 CTAP# Capsules 59 Hepatocellular Carcinoma HCC 59 commercializes oncology 59 Myoblast 59 metastatic adenocarcinoma 59 RhuDex TM 59 HER2 Positive 59 THYROID 59 Nilotinib 59 Interferon beta 1a 59 Unstable Angina 59 Metastatic Melanoma 59 efaproxiral 59 Valopicitabine 59 Severe Sepsis 59 MULTIPLE MYELOMA 59 adriamycin 59 ELACYT 59 haematologic 59 Ductal carcinoma 59 Chronic Heart Failure 59 interferon gamma 1b 59 Rebif interferon beta 1a 59 MELAS 59 Treatment Shows Promise 59 ZACTIMA TM ZD# 59 acute lymphoblastic 59 refractory metastatic 59 neoplasias 59 fallopian tube carcinoma 59 testicular germ cell 59 allogeneic HSCT 59 lymphoproliferative disorders 59 Nesiritide 59 endometrial hyperplasia 59 assessing T DM1 59 Renal Insufficiency 59 precancerous condition 59 Advanced Renal Cell 59 Acute lymphoblastic leukemia 59 deletion 5q 59 relapsing remitting MS RRMS 59 Oesophageal 59 gemcitabine Gemzar ® 59 Interferon beta 59 Cancer AnswerLine 59 Prostatic 59 rituximab Rituxan 59 denileukin diftitox 59 ovarian uterine 59 Multiple Myeloma MM 59 Shows Promise Against 59 Vincristine 59 candesartan cilexetil 59 Meets Primary Endpoint 59 subcutaneous immunoglobulin 59 Slow Progression 59 underwent surgical resection 59 Systemic Sclerosis 59 Mg Uk 59 Lymphocytic 59 Coronary Artery Bypass Graft 59 Slows Progression 59 R lenalidomide 59 J Am Coll 59 Thalomid ® 59 Glioblastoma Multiforme 58 Annamycin 58 Adefovir 58 untreated metastatic pancreatic 58 5 FU leucovorin 58 transplantation HCT 58 mitoxantrone plus 58 Phase 2b Clinical Trial 58 Replacement Therapy 58 gastrointestinal stromal tumors GISTs 58 Recurrent Chest Wall 58 Initiates Clinical Trials 58 complement inhibitor eculizumab 58 Bezielle 58 Glioma 58 Myelodysplastic Syndrome MDS 58 ergot derivatives 58 Lupus Nephritis 58 Adjunctive 58 investigational monoclonal antibody 58 Glatiramer Acetate 58 intrahepatic bile duct 58 tramiprosate Alzhemed TM 58 liver metastasis 58 SKIN CANCER 58 Naive Patients 58 Progressive Multifocal Leukoencephalopathy 58 refractory indolent non 58 metastatic bone 58 Pooled Analysis 58 mild renal insufficiency 58 antibody MAb 58 Myelodysplastic Syndrome 58 mouse xenograft models 58 pancreatic islet cell 58 Hereditary Breast 58 DIAGNOSTIC 58 Initiate Clinical Trial 58 gastrointestinal malignancies 58 dual endothelin receptor antagonist 58 pT2 58 pancreatic prostate 58 premalignant lesion 58 receiving VELCADE 58 Chronic lymphocytic leukemia CLL 58 CHRONIC FATIGUE 58 hematological diseases 58 ductal adenocarcinoma 58 histologic subtype 58 valvular heart disease 58 relapsed acute lymphoblastic 58 Stage IIB 58 Degarelix 58 Drug Shows Promise 58 Medullary thyroid cancer 58 anti angiogenic agents 58 PSORIASIS 58 Investigational Treatment 58 cervix uteri 58 Cardiotoxicity 58 chronic obstructive airway 58 Endometrial 58 Malignant Melanoma 58 indolent follicular non 58 Fingolimod 58 #-# Full Text 58 androgen receptor antagonist 58 Bazedoxifene 58 colorectal lung 58 OVARIAN CANCER 58 Zorbtive TM 58 LSE ASM 58 MEDICATIONS 58 Acute Ischemic Stroke 58 lymphomas leukemias 58 Improved Survival 58 alpha1 antitrypsin deficiency 58 NEW TREATMENT 58 brivanib 58 MAYO CLINIC 58 deCODE AF TM 58 Decitabine 58 Paraplatin ® 58 Vidaza ® 58 CANCER TREATMENT 58 Doxil ® 58 relapsed ALL 58 Bayer HealthCare Onyx Pharmaceuticals 58 GOOD HEALTH 58 BCIRG 58 IN VITRO 58 colorectal adenoma 58 rhabdoid 58 NATRECOR ® 58 LymphoStat B TM 58 vidofludimus 58 Lung transplantation 58 Acute myeloid leukemia 58 Transdermal Patch 58 hMG 58 #:#-# [031] 58 Demonstrates Efficacy 58 thetreatment 58 Hormone Receptor Positive 58 cervical ovarian 58 Peginterferon 58 pancreatic colon 58 Vitaxin 58 nodal metastasis 58 pulmonary metastasis 58 morphometric vertebral fractures 58 Adjuvant therapy 58 Chemotherapy induced 58 Endometrial Cancer 58 hormonally sensitive 58 prostate cancer PCa 58 HMG CoA reductase inhibitors 58 histological diagnosis 58 farletuzumab 58 ductal carcinomas 58 Chronic HCV 58 Introgen ADVEXIN 58 Mg Usa 58 Glufosfamide 58 CANCER SUPPORT 58 CLOTS 58 ara C 58 STRIDE PD 58 Sentinel node biopsy 58 cutaneous lupus 58 Alteplase 58 Oral Fingolimod 58 sorafenib Nexavar 57 Muraglitazar 57 interferon ribavirin 57 idiopathic membranous nephropathy 57 Nonalcoholic fatty liver 57 cell acute lymphoblastic 57 Bosutinib 57 Randomized Double blind 57 Chronic Bronchitis 57 FOLOTYN ® 57 vinorelbine tartrate 57 DCVax 57 Interferon Beta 57 Immunosuppressive 57 Improve Survival 57 acyclovir Zovirax 57 ASSERT 57 LEUKEMIA 57 relapsed leukemia 57 EFFEXOR XR 57 mertansine 57 Virus Linked 57 alfa 2a 57 Carvedilol 57 Temodar temozolomide 57 Cystic 57 #:#-# [024] 57 melphalan prednisone 57 Gastric Cancer 57 aMCI precursor 57 pancreatic ovarian 57 Fulvestrant 57 Celgene Revlimid 57 arthritis PsA 57 Torisel temsirolimus 57 TRAIL R1 57 drug Treanda 57 r hGH 57 Pivotal Phase III 57 Breast Cancer Recurrence 57 cutaneous squamous cell carcinoma 57 tumors GIST 57 Lubiprostone 57 Idiopathic Pulmonary Fibrosis 57 alendronate Fosamax 57 NICE Recommends 57 Pemetrexed 57 oral ridaforolimus 57 lenalidomide Revlimid R 57 Vaccine Shows Promise 57 Dual Antiplatelet Therapy 57 Previously Treated 57 Prolongs Survival 57 valacyclovir Valtrex 57 Polycythemia 57 J Am Acad 57 BRAIN TUMOR 57 pretransplant 57 BR.# 57 Sipuleucel T 57 Novel Oral 57 HBeAg + 57 Cx# [002] 57 gynecologic malignancy 57 ANCA associated 57 Percutaneous Tibial Nerve Stimulation 57 nonsmall cell lung cancer 57 ASTEROID 57 treating cancerous tumors 57 Hepatocellular Carcinoma 57 hypovitaminosis D 57 Completes Patient Enrollment 57 BrachySil TM 57 Initiates Clinical Trial 57 DISEASE 57 Heavy menstrual bleeding 57 Myelofibrosis 57 ATTR CM 57 lichen planus 57 refractory acute myeloid 57 hemoglobinopathies 57 Preclinical Study 57 Natalizumab 57 achieved CCyR 57 refractory Hodgkin 57 Mycophenolate Mofetil 57 lymphoproliferative diseases 57 Proxinium TM 57 vincristine doxorubicin 57 pancreatic adenocarcinoma 57 Pemphigus Vulgaris 57 Relapsing Multiple Sclerosis 57 velafermin 57 terlipressin 57 Crohn colitis 57 Acute Leukemia 57 Uterine cancer 57 toenail onychomycosis 57 IV Busulfex 57 AA Amyloidosis 57 Chronic Sinusitis 57 gastric adenocarcinoma 57 null responder 57 Achieves Primary Endpoint 57 ductal cancer 57 Tezampanel 57 epithelial tumors 57 brivaracetam 57 TAXOTERE R 57 Non Invasive Treatment 57 IMPORTANT SAFETY INFORMATION 57 collagenous colitis 57 Latuda 57 Prevent Stroke 57 SPRYCEL ® 57 ER CHOP 57 stem cell engraftment 57 prostate pancreatic 57 nonalcoholic steatohepatitis NASH 57 Autoimmune Disease 57 Is Well Tolerated 57 Knee Osteoarthritis 57 Lilly Gemzar 57 gastrointestinal stromal tumor GIST 57 Brain Metastases 57 thrombocytosis 57 J Nutr 57 plus DOXIL 57 immunotherapy treatments 57 hepatorenal syndrome 57 B Cell Lymphoma 57 epithelial ovarian 57 XYOTAX TM 57 parathyroid carcinoma 57 Roche Herceptin 57 PEGylated interferon 57 Gemzar ® 57 Endarterectomy 57 leukemia ALL 57 colorectal gastric 57 HERCEPTIN 57 Clavis Pharma ASA 57 pertuzumab 57 acute humoral rejection 57 metastatic lymph nodes 57 Aplidin R 57 radezolid 57 metastatic malignant melanoma 57 HBeAg positive patients 57 TREATMENT OPTIONS 57 systemic amyloidosis 57 non hodgkin lymphoma 57 recurrent NSCLC 57 VITAMIN D 57 cetuximab Erbitux R 57 CANCER RESEARCH 56 Metastatic Prostate Cancer 56 LENALIDOMIDE 56 Inflammatory Markers 56 spinal metastases 56 Zemplar Capsules 56 immunotherapeutic vaccine 56 Elotuzumab 56 Panzem R NCD 56 Mestinon 56 Subgroup Analysis 56 relapsed CLL 56 HuMax EGFr 56 SYMMETRY 56 systemic mastocytosis 56 humanized monoclonal 56 Acute Myelogenous Leukemia 56 pancreatic lung 56 gastro oesophageal reflux 56 Colorectal cancer CRC 56 Candidiasis 56 HEPATITIS 56 Aptivus ® 56 Gleevec imatinib mesylate 56 Chronic Myeloid Leukemia 56 #:#-# [023] 56 alkylating 56 carcinoid tumor 56 Combination Treatment 56 BARACLUDE ® 56 cellular immunotherapy 56 diseases fat malabsorption 56 TTR amyloidosis 56 urologic diseases 56 hPAM4 56 FDA Approvals 56 ANTIBIOTICS 56 familial polyposis 56 Camptosar ® 56 Xeloda ® 56 Patients Undergoing 56 leukemia AML 56 Randomized Study 56 Reduces Mortality 56 MALT lymphoma 56 cardio renal 56 autoantibody positive 56 Relapsing remitting 56 RhuDex 56 Estrogen Receptor 56 Fondaparinux 56 CRLX# 56 Irinotecan 56 metaglidasen 56 Human papillomavirus 56 Drug Combo 56 Improves Survival 56 1mg 2mg 56 Zarnestra 56 Newly Diagnosed Multiple Myeloma 56 surgically resectable 56 2 methoxyestradiol 56 Ascites 56 haematological cancers 56 naïve HCV 56 invasive ductal 56 patientswith 56 novel VDA molecule 56 including eniluracil ADH 56 systemic anaplastic large 56 CC genotype 56 lymphoma leukemia 56 Glycemia 56 squamous cell lung cancer 56 lumiliximab 56 MENOPAUSE 56 Pegloticase 56 cisplatin resistant 56 Myocarditis 56 myeloproliferative neoplasms MPNs 56 RENAL 56 oral Hycamtin 56 Phase 2a Clinical Trial 56 atypical hemolytic uremic syndrome 56 HEART DISEASE 56 Omacetaxine 56 alemtuzumab Campath 56 Brentuximab Vedotin SGN 56 kidney fibrosis 56 locoregional recurrence 56 biologic DMARD 56 Predict Risk 56 Overactive Bladder 56 bronchogenic carcinoma 56 humanized interleukin 6 56 chemoradiation therapy 56 Submits NDA 56 antiproliferative effects 56 Sapacitabine 56 intestinal polyps 56 testicular cancers 56 Randomized Phase 56 Rotavirus Vaccine 56 Gene Linked 56 Cholesterol Lowering Drug 56 AVOREN 56 Crit Rev 56 Acute Myeloid Leukaemia AML 56 number NCT# ClinicalTrials.gov 56 TNF Tumor Necrosis Factor 56 Primary Pulmonary Hypertension 56 Kidney Transplant Patients 56 prospective multicentre 56 urolithiasis 56 Phase III randomized controlled 56 underwent resection 56 Cholangiocarcinoma 56 Bronchodilator 56 cytoreduction 56 metastatic ovarian cancer 56 Aviptadil 56 Modrenal R 56 Newly Diagnosed Patients 56 oral squamous cell 56 Phase 1b clinical trials 56 fosbretabulin 56 CAUTIONS 56 neuroendocrine cancers 56 gastro oesophageal reflux disease 56 clodronate 56 Teva Provides Update 56 phase IIIb 56 HIV HCV coinfected 56 Iron Overload 56 SUTENT ® 56 Adjunctive Therapy 56 5q deletion 56 Hereditary angioedema 56 basal cell carcinoma BCC 56 cholangiocarcinoma 56 OHR/AVR# 56 Acute myeloid leukemia AML 56 CALGB # [002] 56 Romidepsin 56 Rituxan rituximab 56 Vicriviroc 56 generation purine nucleoside 56 Wilm tumor 56 FOLFOX6 56 Pyridorin 56 metastatic HER2 positive 56 Rheumatoid 56 hemodialysis peritoneal dialysis 56 oral clodronate 56 Crohn disease colitis 56 tumor subtype 56 adjuvant cisplatin 56 hA# 56 metastatic castrate resistant 56 Proc Am Soc 56 CHAMPION PCI 56 Denufosol 56 Archexin 56 Chronic Lymphocytic Leukemia 56 prostate carcinoma 56 gemcitabine carboplatin 56 Tyrosine Kinase Inhibitors 56 S#.# [006] 56 breat cancer 56 paclitaxel Taxol 56 Cloretazine R 56 comparator arm 56 immunomodulatory properties 56 familial amyloidotic polyneuropathy FAP 56 Cutaneous T 56 Pharmacokinetics PK 56 CALGB 56 Carotid Revascularization Endarterectomy vs. 56 Elagolix 56 Folfox 56 CHOLESTEROL 56 NOVARTIS 56 SSc 56 osteolytic bone disease 56 Relapsing Remitting Multiple Sclerosis 56 Hydroxyurea 56 Oral Cladribine 56 FOR PATIENTS 56 Trastuzumab 56 fluoropyrimidine 56 peginterferon alpha 2a 56 Renal Cancer 56 Telithromycin 56 unfractionated heparin UFH 56 paraneoplastic 56 lymphocytic leukemia 56 Surgical Treatment 56 Am J Obstet 56 Study Evaluating 56 Diastolic Heart Failure 56 seminoma 56 recurrent glioblastoma multiforme GBM 56 Novartis Femara 56 Albuferon TM 56 Free Full Text 56 Lenalidomide 56 Acute Heart Failure 56 Postmenopausal 56 Fracture Risk 56 Orally administered 56 BRIM2 56 aflibercept VEGF Trap 55 bexarotene 55 Genentech Rituxan 55 Glatiramer acetate 55 FULL PRESCRIBING INFORMATION 55 unresectable stage 55 hemodynamically significant 55 estramustine 55 malignant lymphoma 55 Acute Myocardial Infarction 55 Immunosuppression 55 Inhaled nitric oxide 55 aromatase inhibitors AIs 55 neratinib 55 KRAS mutated 55 Treating Chronic 55 Emerging Therapies 55 overexpress HER2 55 ovarian prostate 55 Actimmune ® 55 ExTRACT TIMI 55 pan HDAC inhibitor 55 Elderly Patients 55 Tarceva TM 55 Non Hodgkin 55 PROCRIT ® 55 paraganglioma 55 BCG refractory carcinoma 55 Tumor Response 55 OncoVAX ® 55 sarcomatoid 55 Crohns disease 55 choriocarcinoma 55 myelofibrosis MF 55 TREATMENTS 55 Leucovorin 55 drug GAP #B# 55 bortezomib Velcade R 55 Antisoma AS# 55 FASLODEX 55 AMEVIVE 55 ASPIRIN 55 confidence interval #.#-#.# 55 phase IIb study 55 anticancer antiviral 55 UM Cancer AnswerLine 55 hematopoietic cancers 55 paclitaxel Taxol ® 55 cytomegalovirus infections 55 Venous Thromboembolism 55 autologous transplants 55 Demonstrates Significant 55 NEW DRUG 55 EURIDIS 55 operable breast cancer 55 Phase 2b Study 55 Glioblastoma Multiforme GBM 55 ritonavir boosted 55 antihormonal therapy 55 postmenopausal hormone replacement 55 relapsed mantle 55 elacytarabine 55 Antiviral Therapy 55 Zemplar 55 metastatic castration resistant 55 Multidrug 55 Phenylketonuria PKU 55 oligodendrogliomas 55 sunitinib malate 55 CYP#A# CYP#D# 55 Phase Ib Clinical Trial 55 Serious Infections 55 HDAC Inhibitor 55 concurrent chemoradiation 55 relapsing multiple sclerosis 55 Gynecologic 55 Aurora Kinase 55 advanced HER2 positive 55 PhG alpha 1 55 Clolar ® 55 lymphoid malignancies 55 Angiotensin Converting Enzyme 55 malignant pleural mesothelioma 55 ovarian lung 55 diabetes mellitus DM 55 SMOKING CESSATION 55 antimitotic 55 HORIZONS AMI 55 Genasense ® 55 doublet chemotherapy 55 SNT-MC#/idebenone 55 Shows Efficacy 55 Tipranavir 55 Myelodysplastic Syndromes 55 Patency 55 capecitabine Xeloda 55 RAV# 55 ONCOLOGY 55 5-fluorouracil/leucovorin 55 urothelial cancer 55 testicular tumors 55 Intra abdominal 55 erlotinib Tarceva 55 targeted radiotherapeutic 55 FOLFOX chemotherapy 55 IMPACT DCM 55 Cell Therapeutics Inc 55 reduce serum phosphate 55 HEART FAILURE 55 INCB# [003] 55 MBRX 55 Randomized Phase II 55 HQK 55 systemic juvenile idiopathic 55 Survival Benefit 55 Lou Gehrigs disease 55 gastrointestinal stromal tumor 55 colo rectal cancer 55 pulmonary hypertension PH 55 chills fever headache 55 discontinued Viread 55 SIADH 55 ACCOMPLISH 55 uterine tumors 55 recurrent glioblastoma 55 Metastatic Colorectal Cancer 55 Stomach Cancer 55 Relapsed Refractory Multiple Myeloma 55 Arch Intern Med 55 LV dysfunction 55 Phase IIa Clinical Trial 55 Appears Safe 55 papillary thyroid carcinoma 55 CLINICAL STUDIES 55 prostate cancer CaP 55 Imatinib mesylate 55 mapatumumab 55 PARKINSON 'S 55 leiomyosarcoma 55 Stanate R 55 Phase IIb Trial 55 Medivation Inc 55 Tyrosine Kinase Inhibitor 55 Silodosin 55 Clostridium difficile Infection 55 Femara letrozole 55 phase IIb clinical 55 node metastases 55 Hyperplasia 55 Acute Respiratory Failure 55 Vandetanib 55 non resectable 55 SIR Spheres 55 DIAGNOSTICS 55 tuberous sclerosis TS 55 TREATMENT OF 55 liposomal formulation 55 HuMax 55 erythematosus SLE 55 metaplasia 55 Pivotal Clinical Trial 55 inherited metabolic disorders 55 ISTODAX ® 55 ixabepilone 55 Anaplastic 55 Ivanhoe Newswire Patients 55 histologically confirmed 55 Long Term Efficacy 55 Onko Sure TM 55 cell lymphoma CTCL 55 TRANSPLANT 55 hormonally responsive 55 polycystic 55 syngeneic 55 alpha 2a 55 Lung Cancer Trial 55 adenomatous 55 Am J Cardiol 55 Kepivance 55 Hematologic 55 Primary Immunodeficiency 55 HLA DR4 55 rALLy 55 antiretroviral naïve 55 refractory cutaneous T 55 CANCER PATIENT 55 receptor tyrosine kinase inhibitor 55 Clinical Trial Data 55 alefacept 55 refractory colorectal cancer 55 aspirin clopidogrel 55 Wilms tumors 55 Small Intestine 55 dexpramipexole 55 haematological malignancies 55 solar keratosis 55 localized renal 55 ILLUSTRATE 55 Multicentre 55 Leukemia Lymphoma 55 PEG IFN 55 ribavirin Copegus ® 55 pT3 55 PHASE III 55 glomerulosclerosis 55 Phase III Trial 55 superficial basal cell carcinoma 55 Phase Ib IIa 55 Amrubicin 55 orally inhaled migraine 55 polycythemia vera PV 55 GISTs 55 Medulloblastoma 55 fluorouracil leucovorin 55 YONDELIS 55 LUPUS 55 Ewings sarcoma 55 Therapy Shows Promise 55 Intracerebral Hemorrhage 55 nasopharyngeal carcinoma 55 Pemphigus 55 interleukin IL -# 55 cervical lymph node 55 Retreatment 55 transcranial Doppler ultrasound 55 nortriptyline Pamelor 55 Benign Prostatic Hyperplasia 55 pheochromocytoma 55 Clostridium difficile infections 55 Bipolar Depression 54 Clinical Outcome 54 vaccine Stimuvax 54 #Gy 54 infliximab Remicade 54 bosentan Tracleer 54 Sevelamer 54 nonmelanoma skin cancers 54 Phase 2b Trial 54 ToGA 54 Cancer Incidence Mortality 54 prostate cancer CRPC 54 Granted Orphan Drug 54 cyclophosphamide doxorubicin vincristine 54 Immunosuppressant 54 Myeloma Patients 54 Completes Enrollment 54 undergoing peritoneal dialysis 54 BIOPHARMA 54 Inc. AMEX YMI 54 uterus womb 54 Hypertensive Patients 54 gemcitabine Gemzar 54 REALITY Trial 54 Deferiprone 54 Skeletal Muscle 54 Castration Resistant Prostate Cancer 54 Moxifloxacin 54 gastrointestinal stromal tumors GIST